National Heart, Lung, and Blood Institute - Research Projects

Active

Assistance listing
93.HL2
Agency
Grant awards
Not on record

Program facts

Treasury account
  • 75-0872-0-1-552

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) funds research projects that advance the prevention and treatment of heart, lung, blood, and sleep conditions under Assistance Listing 93.HL2, with no hard deadline for the next application round currently surfaced in available materials.

The program supports investigator-initiated research projects aligned with NHLBI's core mission. Funded activities include basic science, clinical, and translational research addressing cardiovascular disease, pulmonary disease, blood disorders, and sleep medicine. Applications are evaluated on scientific merit and technical adequacy of experimental design, investigator competency, facility adequacy, budget justification, and relevance to NHLBI program objectives. The program conducts peer review through an initial review group study section followed by secondary review by the National Heart, Lung, and Blood Advisory Council; regular grants proceed from initial submission to award notification in seven to nine months.

Eligible applicants include public and private nonprofit institutions and organizations engaged in biomedical research, for-profit companies, small businesses with fewer than 500 employees, state-designated Indian tribes, individuals and families, and local organizations. Institutions of higher education and hospitals qualify as both nonprofit and for-profit eligible entities depending on organizational structure.

Recipients must maintain financial and programmatic records for three years from the date the annual financial status report is submitted to NIH. Organizations expending $750,000 or more in federal awards annually are subject to single or program-specific audit requirements under 2 CFR 200, Subpart F. The source does not provide a recent grant award portfolio, recent award amounts, or currently open grant opportunities for evaluation of current activity level or funding volume.

Objective and description

Objective

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individ

Description

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individuals so that they can live longer and more fulfilling lives. NHLBI supports research projects that align with fulfilling the mission of the NHLBI.

Eligibility

Applicant eligibility

Local (includes State-designated Indian Tribes; excludes institutions of higher education and hospitals), Public nonprofit institution/organization (includes institutions of higher education and hospitals), Individual/Family, Small business (less than 500 employees), Private nonprofit institution/organization (includes institutions of higher education and hospitals). Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.

Beneficiary eligibility

Any nonprofit or for-profit organization, company or institution engaged in biomedical research.

Uses of assistance

Grants may support stipends, research expenses, supplies, travel, childcare costs, and research training tuition as required to perform the research effort.

Use restrictions

Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research.

How to apply

Criteria for selecting proposals

The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.

Award procedure

All accepted applications are evaluated by an appropriate initial review group (study section). All grant applications receive a final secondary review by the National Heart, Lung, and Blood Advisory Council. Staff inform applicants of the results of the review. If support is contemplated, staff initiate preparation of awards for grants.

Time to approval or disapproval

Regular Grants: From 7 to 9 months.

Renewals

Renewal applications are reviewed in the same manner as new applications.

Appeals

A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available in the NIH Guide at the following URL http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Grant opportunities

Quick answers

What is Assistance Listing 93.HL2?

Assistance Listing 93.HL2 is National Heart, Lung, and Blood Institute - Research Projects, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for National Heart, Lung, and Blood Institute - Research Projects?

Its CFDA number is 93.HL2: Assistance Listing numbers were called CFDA numbers before 2018.

Are there open grant opportunities under 93.HL2?

3 listed opportunities under 93.HL2 are open or forecasted. The latest, Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed), was posted on June 24, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program